BLINCYTO ajouté à une chimiothérapie de consolidation multiphase réduit sensiblement le risque de décès par rapport à la chimiothérapie seule. THOUSAND OAKS, Californie, 30 janvier 2025 /PRNewswire/ — Amgen (NASDAQ:AMGN) annonce ce jour que la Commission européenne (CE) a approuvé…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.